Abiopharma

🔍 van Kralingen Bridget A (Director)

Company: Schrodinger, Inc. (SDGR)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 8,141 shares of Common Stock (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,640.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 13,313 shares of Stock Option (right to buy) at $15.23 per share (Derivative)
  Date: 2026-06-22 | Code: A | Expires: 2036-06-22 | equity_swap_involved: 0 | shares_owned_after: 13,313.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 22, 2026 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.
• F2: Includes 14,808 unvested RSUs.
• F3: The option was granted on June 22, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.